Clinical Trial Update: Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating LH supplementation on endometrial gene expression in poor ovarian responders has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poor Response to Ovulation Induction

Drugs mentioned

• LH supplementation

Snippet

Sponsor: CRG UZ Brussel | Conditions: Poor Response to Ovulation Induction | Phase 4 | Status: WITHDRAWN